Clinical, endocrine, and metabolic effects of two doses of gestrinone in treatment of pelvic endometriosis

M. Yusoff Dawood, M Y Dawood, Charles Obasiolu, C W Obasiolu, Josefina Ramos, J Ramos, F S Khan-Dawood, Firyal S. Khan‐Dawood
American Journal of Obstetrics and Gynecology · 1997 · vol. 176(2) , pp. 387–394 · doi:10.1016/s0002-9378(97)70504-0 · PMID:9065187 · W2060638042
article OA: closed CC0 ⤵ 20 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigated the clinical, endocrine, and metabolic effects of two different doses of gestrinone in patients undergoing treatment for pelvic endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Endometriosis Gestrinone Progesterone Congeners Adult Double-Blind Method Drug Administration Schedule Endometriosis Endometriosis Female Follicle Stimulating Hormone Follicle Stimulating Hormone Gestrinone Gestrinone Humans Luteinizing Hormone Luteinizing Hormone Pelvis Progesterone Congeners Progesterone Congeners Prospective Studies

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (26)

Cited by (20)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:10:52.568893+00:00
License: CC0 · commercial use OK